Biocon Ltd News & Stock Insights Today

The drug shall be used to treat diet and exercise for improvement of glycemic control in adults with type 2 diabetes.

Here are some of the stocks that may see significant price movement today: Interglobe Aviation, Tata Consultancy, Oil India, etc.

Biosimilars revenue grew 18% YoY to ₹2,458 crore in the quarter. This growth was driven by sustained global demand

As per the company’s regulatory filing, Kristy is currently available in the European Union and Canada markets from 2022.

Here are some of the stocks that may see significant price movement today: United Spirits, Biocon, NATCO Pharma, etc.

Here are some of the stocks that may see significant price movement today: Hyundai Motor, Biocon, Zee Entertainment, etc.

Biocon has appointed Kotak Mahindra Capital, Goldman Sachs (India), and BofA Securities India as lead advisors for the transaction

In its filing with the bourses, the company reported that the current contract period of 36 months has been extended for an additional six months.

As per the company’s filing with the bourses, Biocon Biologics has developed and manufactured this injection while Yoshindo Inc.

The operating performance was also good as EBITDA increased 17.7% to ₹1,078.2 crore in March quarter compared with ₹915.9 crore in Q4 FY24.